BridgeBio Pharma (BBIO) EBT Margin (2019 - 2026)
BridgeBio Pharma (BBIO) reported EBT Margin of 61.71% for Q1 2026, up 4312.0% on a YoY basis from 1.4% in Q1 2025, and up 51.15% sequentially from 126.32% in Q4 2025.
BridgeBio Pharma (BBIO) EBT Margin (2019 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 8 years of EBT Margin data on file, last reported at 61.71% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 4312.0% year-over-year to 61.71%; the trailing twelve-month figure through Mar 2026 stood at 117.75% (up 37535.0% YoY), and the FY2025 full-year result was 145.89%, up 9844.0% from the prior year.
- EBT Margin rose to 61.71% in Q1 2026, from 126.32% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 16.58% in Q1 2024 to a low of 43350.3% in Q3 2022.
- A 5-year average of 6597.67% and a median of 4258.25% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 3590303 bps in 2022 and soared 3909205 bps in 2023, its largest moves.
- Tracing BBIO's EBT Margin over 5 years: stood at 8449.36% in 2022, then slumped by 37 bps to 11593.18% in 2023, then soared by 61 bps to 4526.28% in 2024, then surged by 97 bps to 126.32% in 2025, then jumped by 51 bps to 61.71% in 2026.
- Business Quant data shows BBIO's EBT Margin at 61.71% in Q1 2026, 126.32% in Q4 2025, and 154.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -61.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.71% |
| Dec 31, 2025 | -126.32% |
| Sep 30, 2025 | -154.50% |
| Jun 30, 2025 | -164.30% |
| Mar 31, 2025 | -104.82% |
| Dec 31, 2024 | -4,526.28% |
| Sep 30, 2024 | -6,012.23% |
| Jun 30, 2024 | -3,484.50% |
| Mar 31, 2024 | -16.58% |
| Dec 31, 2023 | -11,593.18% |
| Sep 30, 2023 | -4,258.25% |
| Jun 30, 2023 | -10,153.44% |
| Mar 31, 2023 | -8,100.00% |
| Dec 31, 2022 | -8,449.36% |
| Sep 30, 2022 | -43,350.30% |
| Jun 30, 2022 | -136.28% |
| Mar 31, 2022 | -11,468.30% |
| Dec 31, 2021 | -1,880.86% |
| Sep 30, 2021 | -7,447.27% |
| Jun 30, 2021 | -369.30% |